Speaking at a session of the European Parliament, EU health commissioner Stella Kyriakides said the revisions could include stronger obligations for supply of medicines, earlier notifications of shortages and enhanced transparency of stocks.
Other, non-legislative measures are also being taken to keep medicine supplies for EU patients going.
The new strategy, planned for March this year, is set to “secure access to medicines for all patients in need and to avoid disruptions of medicines in the EU”, Kyriakides told the session.
